SlideShare a Scribd company logo
RESEARCH POSTER PRESENTATION DESIGN © 2012
www.PosterPresentations.com
Alcohol consumption has been
implicated in the pathogenesis of head
and neck squamous cell carcinoma
(HNSCC), though its mechanism is
poorly understood. Long non-coding
RNA (lncRNA) is a noncoding RNA that
has a profound effect on numerous
biological processes including
tumorigenesis and oncogenesis. Our
central hypothesis is that alcohol-
mediated dysregulation of lncRNAs is a
key event in HNSCC pathogenesis.
Utilizing TCGA RNA-seq data from 34
HNSCC patients which included alcohol
drinkers and non-drinkers, we analyzed
the expression levels of lncRNAs to
identify a set of differentially expressed
lncRNAs due to alcohol consumption.
Normal oral keratinocytes were
exposed to ethanol and acetaldehyde
to validate the RNA sequencing results
we obtained. A long-term survival
analysis was then conducted on the
verified lncRNAs utilizing a Cox
Proportional-Hazards regression model
and Kaplan-Meier survival curve. We
identified two lncRNAs: lnc-PSD4-1
and the various splice variants of lnc-
NETO-1 that were differentially
expressed due to alcohol consumption
from RNA-seq analysis of the clinical
data. The oral keratinocytes exposed to
alcohol and acetaldehyde also
demonstrated dysregulation of these
two lncRNAs, validating the RNA-seq
analysis. In addition, low expression of
lnc-PSD4-1:14 showed a strong
correlation with higher survival rates.
lnc-PSD4-1:14 and lnc-NETO-1
potentially play a key role in the early
pathogenesis of HNSCC since they are
dysregulated in both clinical data and
in vitro experiments mimicking the
effects of alcohol use.
Abstract
RNA-seq Analysis
RNA-seq libraries
composed of 34 HNSCC
patients, 17 drinkers and
17 nondrinkers were
obtained from The
Cancer Genome Atlas.
The BEDtools utility
coverageBed was utilized
to generate lncRNA read
counts (integer values of
expression level). These
read counts were then
put through a lncRNA
differential expression
analysis comparing
drinkers versus
nondrinkers.
Materials and Methods
Differentially Expressed lncRNAs
RNA-Seq differential expression analysis
between drinkers and nondrinkers revealed
11 statistically significant lncRNAs.
In Vitro Verification
Of the 11 lncRNAs identified in the RNA-seq
analysis, two were verified: PSD4-1 (including
PSD4-1:14) and NETO1-1, with both having
increased expression levels in the ethanol and
acetaldehyde treated samples compared to
the non-treated controls.
Long-Term Survival Analysis
Low expressions of PSD4-1:14 were highly
correlated with overall better patient survival
in both univariate and multivariate models.
Results Conclusions
The increased expression of NETO1-1
and PSD4-1:14 in both HNSCC patient
clinical samples and in vitro models of
alcohol usage suggest that NETO1-1
and PSD4-1:14 may act as promoters
of oncogenes. While further study is
necessary to understand the molecular
mechanisms by which these lncRNAs
work, PSD4-1 and NETO1-1 hold
promise as potential biomarkers, and
therapeutic targets of HSNCC, that
could lead to improvement in the
treatment of this disease.
Figure Legend
1) Deng G, Sui G (2013) Noncoding RNA in oncogenesis: a new era of
identifying key players. Int J Mol Sci 14: 18319-18349.
2) Homann N, Jousimies-Somer H, Jokelainen K, Heine R, Salaspuro M
(1997) High acetaldehyde levels in saliva after ethanol consumption:
methodological aspects and pathogenetic implications. Carcinogenesis
18: 1739-1743.
3) Hashibe M, Brennan P, Benhamou S, Castellsague X, Chen C, et al.
(2007) Alcohol drinking in never users of tobacco, cigarette smoking in
never drinkers, and the risk of head and neck cancer: pooled analysis
in the International Head and Neck Cancer Epidemiology Consortium.
J Natl Cancer Inst 99: 777-789.
Acknowledgments
• Calit2 and Qualcomm Institute Summer Scholar Program
• Dr. Jessica Wang-Rodriguez
1Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, University of California San Diego
2 Veterans Administration Medical Center and Department of Pathology, University of California San Diego
Pranav Singh1 Vicky Yu1, Elham Rahimy1, Hao Zheng1, Selena Z. Kuo1, Elizabeth Kim1, Weg M. Ongkeko1.
Jessica Wang-Rodriguez2
RNA-seq analysis identifies key long non-coding RNAs connected to the
pathogenesis of alcohol-associated head and neck squamous cell carcinoma
Log(2)FC Log(2)CPM p-value FDR
lnc-SLC39A11-2:7 4.194151 3.878865 1.94E-07 0.001085
lnc-SLC39A11-2:5 4.140367 3.885084 2.44E-07 0.001085
lnc-SLC39A11-2:6 4.142305 3.884648 2.46E-07 0.001085
lnc-LAMB3-1:1 -2.581367 6.606811 2.54E-06 0.008414
lnc-CCL18-1:1 -2.190396 5.522936 5.69E-06 0.015064
lnc-NETO1-1:9 3.351077 3.585717 1.56E-05 0.022272
lnc-NETO1-1:3 3.364047 3.615927 1.63E-05 0.022272
lnc-NETO1-1:2 3.362404 3.616193 1.64E-05 0.022272
lnc-NETO1-1:4 3.347929 3.625721 1.68E-05 0.022272
lnc-NETO1-1:6 3.34735 3.624247 1.68E-05 0.022272
lnc-PSD4-1:14 1.669653 1.020086 2.74E-05 0.032967
lnc-SPANXA2-2:1 2.367287 2.927082 3.36E-05 0.037051
lnc-AC002472.13.1-1:1 -1.862271 1.547773 4.26E-05 0.041177
lnc-ERC1-1:2 -3.066857 4.256589 4.98E-05 0.041177
lnc-FBXL14-1:1 -3.066857 4.256589 4.98E-05 0.041177
lnc-ERC1-1:3 -3.066857 4.256589 4.98E-05 0.041177
lnc-KTN1-AS1-1:6 -2.463648 1.922281 5.81E-05 0.042703
Based upon
low expression
Univariate
Hazard Ratio
(95% CI)
p-value Multivariate
Hazard Ratio
(95% CI)
p-value
LncRNA PSD4-
1:14
0.267150
( 0.072234-
0.988021)
0.047926 0.236208
(0.062212-
0.896836)
0.034013
Ethanol/Acetaldehyde Treatments
We treated the normal oral keratinocytes
(OKF4, OKF6) with increasing dosages of 200
proof ethanol: 0%, 0.1%, and 0.3% ethanol by
volume. To represent long-term alcohol use,
we treated the cells every 24 hours with
ethanol diluted in medium for a period of 28
days. We also repeated treatment with
acetaldehyde, the first metabolite of ingested
alcohol in the human body. OKF4 and OKF6
were treated with acetaldehyde with effective
concentrations of 0 µM, 75 µM, 150 µM, 300
µM and 1000 µM in medium for a period of
48 hours with acetaldehyde added every 4
hours and media changed every 8 hours.
Quantitative RT-PCR
In vitro lncRNA expression was calculated by
method of qRT-PCR on the ethanol and
acetaldehyde treated cell lines with GAPDH
acting as the endogenous control for gene
expression.
Survival Data Analysis
Utilizing the original 34 patient cohort and
clinical information provided by the TCGA, we
correlated the expression levels of key
dysregulated lncRNAs with the long-term
survival of the patients. A Cox Proportional-
Hazards regression model was then utilized
to determine both univariate and multivariate
survival hazard ratios for the lncRNAs based
upon a low expression.
References
1) Heatmap depicting normalized lncRNA
expression levels (in the form of counts per
million) across the drinker and non-drinker
cohorts using 34 HNSCC patients. Top 100
differentially expressed lncRNAs shown,
including ones that do not have FDR < .05.
2) Panel of Differentially Expressed lncRNAs
with FDR between drinkers and nondrinkers.
NETO1-1 and lnc-SLC39A11-2 are
represented by different splice variants.
3) qRT-PCR analysis of ethanol-treated and
acetaldehyde cell lines, OKF4 and OKF6,
demonstrate that both PSD4-1 and NETO1-
1 are dysregulated by alcohol. Error bars
represent standard deviation.
4) Survival information for PSD4-1:14 in both
univariate and multivariate models
demonstrates a strong correlation with low
expression of PSD4-1:14 and better overall
survival.
5) Kaplan-Meier survival graph depicting a
correlation between low expression of lnc-
PSD4-1:14 and better survival.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

More Related Content

What's hot

Sequencing the circulating and infiltrating T-cell repertoire on the Ion S5TM
Sequencing the circulating and infiltrating T-cell repertoire on the Ion S5TMSequencing the circulating and infiltrating T-cell repertoire on the Ion S5TM
Sequencing the circulating and infiltrating T-cell repertoire on the Ion S5TM
Thermo Fisher Scientific
 
Rare Mutation Analysis Using Digital PCR on QuantStudio™ 3D to Verify Ion Amp...
Rare Mutation Analysis Using Digital PCR on QuantStudio™ 3D to Verify Ion Amp...Rare Mutation Analysis Using Digital PCR on QuantStudio™ 3D to Verify Ion Amp...
Rare Mutation Analysis Using Digital PCR on QuantStudio™ 3D to Verify Ion Amp...
Thermo Fisher Scientific
 
An NGS workflow to detect down to 0.1% allelic frequency in cfDNA
An NGS workflow to detect down to 0.1% allelic frequency in cfDNAAn NGS workflow to detect down to 0.1% allelic frequency in cfDNA
An NGS workflow to detect down to 0.1% allelic frequency in cfDNA
Thermo Fisher Scientific
 
IRJET- Silencing of hnRNP A1 and hnRNP A2/B1 Downregulates the Expression of ...
IRJET- Silencing of hnRNP A1 and hnRNP A2/B1 Downregulates the Expression of ...IRJET- Silencing of hnRNP A1 and hnRNP A2/B1 Downregulates the Expression of ...
IRJET- Silencing of hnRNP A1 and hnRNP A2/B1 Downregulates the Expression of ...
IRJET Journal
 
Gene expression profile of the tumor microenvironment from 40 NSCLC FFPE and ...
Gene expression profile of the tumor microenvironment from 40 NSCLC FFPE and ...Gene expression profile of the tumor microenvironment from 40 NSCLC FFPE and ...
Gene expression profile of the tumor microenvironment from 40 NSCLC FFPE and ...
Thermo Fisher Scientific
 
Advanced miRNA Expression Analysis: miRNA and its Role in Human Disease Webin...
Advanced miRNA Expression Analysis: miRNA and its Role in Human Disease Webin...Advanced miRNA Expression Analysis: miRNA and its Role in Human Disease Webin...
Advanced miRNA Expression Analysis: miRNA and its Role in Human Disease Webin...
QIAGEN
 
Biofluid miRNA profiling: from sample to biomarker: miRNA and its Role in Hum...
Biofluid miRNA profiling: from sample to biomarker: miRNA and its Role in Hum...Biofluid miRNA profiling: from sample to biomarker: miRNA and its Role in Hum...
Biofluid miRNA profiling: from sample to biomarker: miRNA and its Role in Hum...
QIAGEN
 
A next Generation Sequencing Approach to Detect Large Rearrangements in BRCA1...
A next Generation Sequencing Approach to Detect Large Rearrangements in BRCA1...A next Generation Sequencing Approach to Detect Large Rearrangements in BRCA1...
A next Generation Sequencing Approach to Detect Large Rearrangements in BRCA1...
Thermo Fisher Scientific
 
Q biomarkersomaticmutation
Q biomarkersomaticmutationQ biomarkersomaticmutation
Q biomarkersomaticmutationElsa von Licy
 
Multiplex TaqMan Assays for Rare Mutation Analysis Using Digital PCR
Multiplex TaqMan Assays for Rare Mutation Analysis Using Digital PCRMultiplex TaqMan Assays for Rare Mutation Analysis Using Digital PCR
Multiplex TaqMan Assays for Rare Mutation Analysis Using Digital PCR
Thermo Fisher Scientific
 
Technical Guide to Qiagen PCR Arrays - Download the Guide
Technical Guide to Qiagen PCR Arrays - Download the GuideTechnical Guide to Qiagen PCR Arrays - Download the Guide
Technical Guide to Qiagen PCR Arrays - Download the Guide
QIAGEN
 
Dominique McCoy PCR paper
Dominique McCoy PCR paperDominique McCoy PCR paper
Dominique McCoy PCR paperDominique McCoy
 
Development of a next-generation (NGS) assay for pediatric, childhood, and yo...
Development of a next-generation (NGS) assay for pediatric, childhood, and yo...Development of a next-generation (NGS) assay for pediatric, childhood, and yo...
Development of a next-generation (NGS) assay for pediatric, childhood, and yo...
Thermo Fisher Scientific
 
1073957 wp rt2_profilerapp_1012
1073957 wp rt2_profilerapp_10121073957 wp rt2_profilerapp_1012
1073957 wp rt2_profilerapp_1012Elsa von Licy
 
Deeper Insight into Transcriptomes! Download the Flyer
Deeper Insight into Transcriptomes! Download the FlyerDeeper Insight into Transcriptomes! Download the Flyer
Deeper Insight into Transcriptomes! Download the Flyer
QIAGEN
 
Successful detection of 40 COSMIC hotspot mutations at allelic frequency belo...
Successful detection of 40 COSMIC hotspot mutations at allelic frequency belo...Successful detection of 40 COSMIC hotspot mutations at allelic frequency belo...
Successful detection of 40 COSMIC hotspot mutations at allelic frequency belo...
Thermo Fisher Scientific
 
Targeted RNAseq for Gene Expression Using Unique Molecular Indexes (UMIs): In...
Targeted RNAseq for Gene Expression Using Unique Molecular Indexes (UMIs): In...Targeted RNAseq for Gene Expression Using Unique Molecular Indexes (UMIs): In...
Targeted RNAseq for Gene Expression Using Unique Molecular Indexes (UMIs): In...
QIAGEN
 
research paper presentation: HYBRID CAPTURE BASED NGS FOR GENOMIC PROFILING ...
research paper presentation: HYBRID CAPTURE BASED NGS  FOR GENOMIC PROFILING ...research paper presentation: HYBRID CAPTURE BASED NGS  FOR GENOMIC PROFILING ...
research paper presentation: HYBRID CAPTURE BASED NGS FOR GENOMIC PROFILING ...
Ikram Ullah
 
5 Tips for Successful qRT-PCR Results Infographic
5 Tips for Successful qRT-PCR Results Infographic5 Tips for Successful qRT-PCR Results Infographic
5 Tips for Successful qRT-PCR Results Infographic
QIAGEN
 
Verification of an Ion AmpliSeq™ RNA Fusion Lung Cancer Research Panel, workf...
Verification of an Ion AmpliSeq™ RNA Fusion Lung Cancer Research Panel, workf...Verification of an Ion AmpliSeq™ RNA Fusion Lung Cancer Research Panel, workf...
Verification of an Ion AmpliSeq™ RNA Fusion Lung Cancer Research Panel, workf...
Thermo Fisher Scientific
 

What's hot (20)

Sequencing the circulating and infiltrating T-cell repertoire on the Ion S5TM
Sequencing the circulating and infiltrating T-cell repertoire on the Ion S5TMSequencing the circulating and infiltrating T-cell repertoire on the Ion S5TM
Sequencing the circulating and infiltrating T-cell repertoire on the Ion S5TM
 
Rare Mutation Analysis Using Digital PCR on QuantStudio™ 3D to Verify Ion Amp...
Rare Mutation Analysis Using Digital PCR on QuantStudio™ 3D to Verify Ion Amp...Rare Mutation Analysis Using Digital PCR on QuantStudio™ 3D to Verify Ion Amp...
Rare Mutation Analysis Using Digital PCR on QuantStudio™ 3D to Verify Ion Amp...
 
An NGS workflow to detect down to 0.1% allelic frequency in cfDNA
An NGS workflow to detect down to 0.1% allelic frequency in cfDNAAn NGS workflow to detect down to 0.1% allelic frequency in cfDNA
An NGS workflow to detect down to 0.1% allelic frequency in cfDNA
 
IRJET- Silencing of hnRNP A1 and hnRNP A2/B1 Downregulates the Expression of ...
IRJET- Silencing of hnRNP A1 and hnRNP A2/B1 Downregulates the Expression of ...IRJET- Silencing of hnRNP A1 and hnRNP A2/B1 Downregulates the Expression of ...
IRJET- Silencing of hnRNP A1 and hnRNP A2/B1 Downregulates the Expression of ...
 
Gene expression profile of the tumor microenvironment from 40 NSCLC FFPE and ...
Gene expression profile of the tumor microenvironment from 40 NSCLC FFPE and ...Gene expression profile of the tumor microenvironment from 40 NSCLC FFPE and ...
Gene expression profile of the tumor microenvironment from 40 NSCLC FFPE and ...
 
Advanced miRNA Expression Analysis: miRNA and its Role in Human Disease Webin...
Advanced miRNA Expression Analysis: miRNA and its Role in Human Disease Webin...Advanced miRNA Expression Analysis: miRNA and its Role in Human Disease Webin...
Advanced miRNA Expression Analysis: miRNA and its Role in Human Disease Webin...
 
Biofluid miRNA profiling: from sample to biomarker: miRNA and its Role in Hum...
Biofluid miRNA profiling: from sample to biomarker: miRNA and its Role in Hum...Biofluid miRNA profiling: from sample to biomarker: miRNA and its Role in Hum...
Biofluid miRNA profiling: from sample to biomarker: miRNA and its Role in Hum...
 
A next Generation Sequencing Approach to Detect Large Rearrangements in BRCA1...
A next Generation Sequencing Approach to Detect Large Rearrangements in BRCA1...A next Generation Sequencing Approach to Detect Large Rearrangements in BRCA1...
A next Generation Sequencing Approach to Detect Large Rearrangements in BRCA1...
 
Q biomarkersomaticmutation
Q biomarkersomaticmutationQ biomarkersomaticmutation
Q biomarkersomaticmutation
 
Multiplex TaqMan Assays for Rare Mutation Analysis Using Digital PCR
Multiplex TaqMan Assays for Rare Mutation Analysis Using Digital PCRMultiplex TaqMan Assays for Rare Mutation Analysis Using Digital PCR
Multiplex TaqMan Assays for Rare Mutation Analysis Using Digital PCR
 
Technical Guide to Qiagen PCR Arrays - Download the Guide
Technical Guide to Qiagen PCR Arrays - Download the GuideTechnical Guide to Qiagen PCR Arrays - Download the Guide
Technical Guide to Qiagen PCR Arrays - Download the Guide
 
Dominique McCoy PCR paper
Dominique McCoy PCR paperDominique McCoy PCR paper
Dominique McCoy PCR paper
 
Development of a next-generation (NGS) assay for pediatric, childhood, and yo...
Development of a next-generation (NGS) assay for pediatric, childhood, and yo...Development of a next-generation (NGS) assay for pediatric, childhood, and yo...
Development of a next-generation (NGS) assay for pediatric, childhood, and yo...
 
1073957 wp rt2_profilerapp_1012
1073957 wp rt2_profilerapp_10121073957 wp rt2_profilerapp_1012
1073957 wp rt2_profilerapp_1012
 
Deeper Insight into Transcriptomes! Download the Flyer
Deeper Insight into Transcriptomes! Download the FlyerDeeper Insight into Transcriptomes! Download the Flyer
Deeper Insight into Transcriptomes! Download the Flyer
 
Successful detection of 40 COSMIC hotspot mutations at allelic frequency belo...
Successful detection of 40 COSMIC hotspot mutations at allelic frequency belo...Successful detection of 40 COSMIC hotspot mutations at allelic frequency belo...
Successful detection of 40 COSMIC hotspot mutations at allelic frequency belo...
 
Targeted RNAseq for Gene Expression Using Unique Molecular Indexes (UMIs): In...
Targeted RNAseq for Gene Expression Using Unique Molecular Indexes (UMIs): In...Targeted RNAseq for Gene Expression Using Unique Molecular Indexes (UMIs): In...
Targeted RNAseq for Gene Expression Using Unique Molecular Indexes (UMIs): In...
 
research paper presentation: HYBRID CAPTURE BASED NGS FOR GENOMIC PROFILING ...
research paper presentation: HYBRID CAPTURE BASED NGS  FOR GENOMIC PROFILING ...research paper presentation: HYBRID CAPTURE BASED NGS  FOR GENOMIC PROFILING ...
research paper presentation: HYBRID CAPTURE BASED NGS FOR GENOMIC PROFILING ...
 
5 Tips for Successful qRT-PCR Results Infographic
5 Tips for Successful qRT-PCR Results Infographic5 Tips for Successful qRT-PCR Results Infographic
5 Tips for Successful qRT-PCR Results Infographic
 
Verification of an Ion AmpliSeq™ RNA Fusion Lung Cancer Research Panel, workf...
Verification of an Ion AmpliSeq™ RNA Fusion Lung Cancer Research Panel, workf...Verification of an Ion AmpliSeq™ RNA Fusion Lung Cancer Research Panel, workf...
Verification of an Ion AmpliSeq™ RNA Fusion Lung Cancer Research Panel, workf...
 

Similar to Calit2Poster

Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
JohnJulie1
 
Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
AnonIshanvi
 
Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
daranisaha
 
Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
EditorSara
 
Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
NainaAnon
 
Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
semualkaira
 
Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
semualkaira
 
MicroRNA Stability in FFPE Tissue Samples: Dependence on GC Content
MicroRNA Stability in FFPE Tissue Samples: Dependence on GC ContentMicroRNA Stability in FFPE Tissue Samples: Dependence on GC Content
MicroRNA Stability in FFPE Tissue Samples: Dependence on GC Content
kalahawer
 
Long non coding RNA or lncRNA
Long non coding RNA or lncRNALong non coding RNA or lncRNA
Long non coding RNA or lncRNA
MOHIT GOSWAMI
 
Hotspot mutation and fusion transcript detection from the same non-small cell...
Hotspot mutation and fusion transcript detection from the same non-small cell...Hotspot mutation and fusion transcript detection from the same non-small cell...
Hotspot mutation and fusion transcript detection from the same non-small cell...
Thermo Fisher Scientific
 
Total RNA Discovery for RNA Biomarker Development Webinar
Total RNA Discovery for RNA Biomarker Development WebinarTotal RNA Discovery for RNA Biomarker Development Webinar
Total RNA Discovery for RNA Biomarker Development Webinar
QIAGEN
 
Selective Activation of Alpha 7 Nicotinic Receptor Antagonizes Apoptosis in R...
Selective Activation of Alpha 7 Nicotinic Receptor Antagonizes Apoptosis in R...Selective Activation of Alpha 7 Nicotinic Receptor Antagonizes Apoptosis in R...
Selective Activation of Alpha 7 Nicotinic Receptor Antagonizes Apoptosis in R...
ANALYTICAL AND QUANTITATIVE CYTOPATHOLOGY AND HISTOPATHOLOGY
 
9979-152032-3-PB (2)
9979-152032-3-PB (2)9979-152032-3-PB (2)
9979-152032-3-PB (2)Andrew Hinton
 
Purification of total RNA from peripheral blood mononuclear cells - Download ...
Purification of total RNA from peripheral blood mononuclear cells - Download ...Purification of total RNA from peripheral blood mononuclear cells - Download ...
Purification of total RNA from peripheral blood mononuclear cells - Download ...
QIAGEN
 
ROLE OF ADD1 GENE IN HYPERTENSIVE PATIENTS.pptx
ROLE OF ADD1 GENE IN HYPERTENSIVE PATIENTS.pptxROLE OF ADD1 GENE IN HYPERTENSIVE PATIENTS.pptx
ROLE OF ADD1 GENE IN HYPERTENSIVE PATIENTS.pptx
RehanaRamzan3
 
Long non coding RNA and Their clinical perspective
Long non coding RNA and Their clinical perspectiveLong non coding RNA and Their clinical perspective
Long non coding RNA and Their clinical perspective
MOHIT GOSWAMI
 
Biochim Biophys Acta. 2014
Biochim Biophys Acta. 2014Biochim Biophys Acta. 2014
Biochim Biophys Acta. 2014Laia Llovera
 
Combined Analysis of Micro RNA and Proteomic Profiles and Interactions in Pat...
Combined Analysis of Micro RNA and Proteomic Profiles and Interactions in Pat...Combined Analysis of Micro RNA and Proteomic Profiles and Interactions in Pat...
Combined Analysis of Micro RNA and Proteomic Profiles and Interactions in Pat...
JohnJulie1
 

Similar to Calit2Poster (20)

Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
 
Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
 
Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
 
Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
 
Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
 
Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
 
Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
Deadenylase Expression in Small Cell Lung Cancer Related To Clinical Characte...
 
MicroRNA Stability in FFPE Tissue Samples: Dependence on GC Content
MicroRNA Stability in FFPE Tissue Samples: Dependence on GC ContentMicroRNA Stability in FFPE Tissue Samples: Dependence on GC Content
MicroRNA Stability in FFPE Tissue Samples: Dependence on GC Content
 
Long non coding RNA or lncRNA
Long non coding RNA or lncRNALong non coding RNA or lncRNA
Long non coding RNA or lncRNA
 
Hotspot mutation and fusion transcript detection from the same non-small cell...
Hotspot mutation and fusion transcript detection from the same non-small cell...Hotspot mutation and fusion transcript detection from the same non-small cell...
Hotspot mutation and fusion transcript detection from the same non-small cell...
 
Sot2007
Sot2007Sot2007
Sot2007
 
Total RNA Discovery for RNA Biomarker Development Webinar
Total RNA Discovery for RNA Biomarker Development WebinarTotal RNA Discovery for RNA Biomarker Development Webinar
Total RNA Discovery for RNA Biomarker Development Webinar
 
Selective Activation of Alpha 7 Nicotinic Receptor Antagonizes Apoptosis in R...
Selective Activation of Alpha 7 Nicotinic Receptor Antagonizes Apoptosis in R...Selective Activation of Alpha 7 Nicotinic Receptor Antagonizes Apoptosis in R...
Selective Activation of Alpha 7 Nicotinic Receptor Antagonizes Apoptosis in R...
 
9979-152032-3-PB (2)
9979-152032-3-PB (2)9979-152032-3-PB (2)
9979-152032-3-PB (2)
 
Purification of total RNA from peripheral blood mononuclear cells - Download ...
Purification of total RNA from peripheral blood mononuclear cells - Download ...Purification of total RNA from peripheral blood mononuclear cells - Download ...
Purification of total RNA from peripheral blood mononuclear cells - Download ...
 
ROLE OF ADD1 GENE IN HYPERTENSIVE PATIENTS.pptx
ROLE OF ADD1 GENE IN HYPERTENSIVE PATIENTS.pptxROLE OF ADD1 GENE IN HYPERTENSIVE PATIENTS.pptx
ROLE OF ADD1 GENE IN HYPERTENSIVE PATIENTS.pptx
 
Duzkale_2011_CLL biomarker LDOC1
Duzkale_2011_CLL biomarker LDOC1Duzkale_2011_CLL biomarker LDOC1
Duzkale_2011_CLL biomarker LDOC1
 
Long non coding RNA and Their clinical perspective
Long non coding RNA and Their clinical perspectiveLong non coding RNA and Their clinical perspective
Long non coding RNA and Their clinical perspective
 
Biochim Biophys Acta. 2014
Biochim Biophys Acta. 2014Biochim Biophys Acta. 2014
Biochim Biophys Acta. 2014
 
Combined Analysis of Micro RNA and Proteomic Profiles and Interactions in Pat...
Combined Analysis of Micro RNA and Proteomic Profiles and Interactions in Pat...Combined Analysis of Micro RNA and Proteomic Profiles and Interactions in Pat...
Combined Analysis of Micro RNA and Proteomic Profiles and Interactions in Pat...
 

Calit2Poster

  • 1. RESEARCH POSTER PRESENTATION DESIGN © 2012 www.PosterPresentations.com Alcohol consumption has been implicated in the pathogenesis of head and neck squamous cell carcinoma (HNSCC), though its mechanism is poorly understood. Long non-coding RNA (lncRNA) is a noncoding RNA that has a profound effect on numerous biological processes including tumorigenesis and oncogenesis. Our central hypothesis is that alcohol- mediated dysregulation of lncRNAs is a key event in HNSCC pathogenesis. Utilizing TCGA RNA-seq data from 34 HNSCC patients which included alcohol drinkers and non-drinkers, we analyzed the expression levels of lncRNAs to identify a set of differentially expressed lncRNAs due to alcohol consumption. Normal oral keratinocytes were exposed to ethanol and acetaldehyde to validate the RNA sequencing results we obtained. A long-term survival analysis was then conducted on the verified lncRNAs utilizing a Cox Proportional-Hazards regression model and Kaplan-Meier survival curve. We identified two lncRNAs: lnc-PSD4-1 and the various splice variants of lnc- NETO-1 that were differentially expressed due to alcohol consumption from RNA-seq analysis of the clinical data. The oral keratinocytes exposed to alcohol and acetaldehyde also demonstrated dysregulation of these two lncRNAs, validating the RNA-seq analysis. In addition, low expression of lnc-PSD4-1:14 showed a strong correlation with higher survival rates. lnc-PSD4-1:14 and lnc-NETO-1 potentially play a key role in the early pathogenesis of HNSCC since they are dysregulated in both clinical data and in vitro experiments mimicking the effects of alcohol use. Abstract RNA-seq Analysis RNA-seq libraries composed of 34 HNSCC patients, 17 drinkers and 17 nondrinkers were obtained from The Cancer Genome Atlas. The BEDtools utility coverageBed was utilized to generate lncRNA read counts (integer values of expression level). These read counts were then put through a lncRNA differential expression analysis comparing drinkers versus nondrinkers. Materials and Methods Differentially Expressed lncRNAs RNA-Seq differential expression analysis between drinkers and nondrinkers revealed 11 statistically significant lncRNAs. In Vitro Verification Of the 11 lncRNAs identified in the RNA-seq analysis, two were verified: PSD4-1 (including PSD4-1:14) and NETO1-1, with both having increased expression levels in the ethanol and acetaldehyde treated samples compared to the non-treated controls. Long-Term Survival Analysis Low expressions of PSD4-1:14 were highly correlated with overall better patient survival in both univariate and multivariate models. Results Conclusions The increased expression of NETO1-1 and PSD4-1:14 in both HNSCC patient clinical samples and in vitro models of alcohol usage suggest that NETO1-1 and PSD4-1:14 may act as promoters of oncogenes. While further study is necessary to understand the molecular mechanisms by which these lncRNAs work, PSD4-1 and NETO1-1 hold promise as potential biomarkers, and therapeutic targets of HSNCC, that could lead to improvement in the treatment of this disease. Figure Legend 1) Deng G, Sui G (2013) Noncoding RNA in oncogenesis: a new era of identifying key players. Int J Mol Sci 14: 18319-18349. 2) Homann N, Jousimies-Somer H, Jokelainen K, Heine R, Salaspuro M (1997) High acetaldehyde levels in saliva after ethanol consumption: methodological aspects and pathogenetic implications. Carcinogenesis 18: 1739-1743. 3) Hashibe M, Brennan P, Benhamou S, Castellsague X, Chen C, et al. (2007) Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst 99: 777-789. Acknowledgments • Calit2 and Qualcomm Institute Summer Scholar Program • Dr. Jessica Wang-Rodriguez 1Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, University of California San Diego 2 Veterans Administration Medical Center and Department of Pathology, University of California San Diego Pranav Singh1 Vicky Yu1, Elham Rahimy1, Hao Zheng1, Selena Z. Kuo1, Elizabeth Kim1, Weg M. Ongkeko1. Jessica Wang-Rodriguez2 RNA-seq analysis identifies key long non-coding RNAs connected to the pathogenesis of alcohol-associated head and neck squamous cell carcinoma Log(2)FC Log(2)CPM p-value FDR lnc-SLC39A11-2:7 4.194151 3.878865 1.94E-07 0.001085 lnc-SLC39A11-2:5 4.140367 3.885084 2.44E-07 0.001085 lnc-SLC39A11-2:6 4.142305 3.884648 2.46E-07 0.001085 lnc-LAMB3-1:1 -2.581367 6.606811 2.54E-06 0.008414 lnc-CCL18-1:1 -2.190396 5.522936 5.69E-06 0.015064 lnc-NETO1-1:9 3.351077 3.585717 1.56E-05 0.022272 lnc-NETO1-1:3 3.364047 3.615927 1.63E-05 0.022272 lnc-NETO1-1:2 3.362404 3.616193 1.64E-05 0.022272 lnc-NETO1-1:4 3.347929 3.625721 1.68E-05 0.022272 lnc-NETO1-1:6 3.34735 3.624247 1.68E-05 0.022272 lnc-PSD4-1:14 1.669653 1.020086 2.74E-05 0.032967 lnc-SPANXA2-2:1 2.367287 2.927082 3.36E-05 0.037051 lnc-AC002472.13.1-1:1 -1.862271 1.547773 4.26E-05 0.041177 lnc-ERC1-1:2 -3.066857 4.256589 4.98E-05 0.041177 lnc-FBXL14-1:1 -3.066857 4.256589 4.98E-05 0.041177 lnc-ERC1-1:3 -3.066857 4.256589 4.98E-05 0.041177 lnc-KTN1-AS1-1:6 -2.463648 1.922281 5.81E-05 0.042703 Based upon low expression Univariate Hazard Ratio (95% CI) p-value Multivariate Hazard Ratio (95% CI) p-value LncRNA PSD4- 1:14 0.267150 ( 0.072234- 0.988021) 0.047926 0.236208 (0.062212- 0.896836) 0.034013 Ethanol/Acetaldehyde Treatments We treated the normal oral keratinocytes (OKF4, OKF6) with increasing dosages of 200 proof ethanol: 0%, 0.1%, and 0.3% ethanol by volume. To represent long-term alcohol use, we treated the cells every 24 hours with ethanol diluted in medium for a period of 28 days. We also repeated treatment with acetaldehyde, the first metabolite of ingested alcohol in the human body. OKF4 and OKF6 were treated with acetaldehyde with effective concentrations of 0 µM, 75 µM, 150 µM, 300 µM and 1000 µM in medium for a period of 48 hours with acetaldehyde added every 4 hours and media changed every 8 hours. Quantitative RT-PCR In vitro lncRNA expression was calculated by method of qRT-PCR on the ethanol and acetaldehyde treated cell lines with GAPDH acting as the endogenous control for gene expression. Survival Data Analysis Utilizing the original 34 patient cohort and clinical information provided by the TCGA, we correlated the expression levels of key dysregulated lncRNAs with the long-term survival of the patients. A Cox Proportional- Hazards regression model was then utilized to determine both univariate and multivariate survival hazard ratios for the lncRNAs based upon a low expression. References 1) Heatmap depicting normalized lncRNA expression levels (in the form of counts per million) across the drinker and non-drinker cohorts using 34 HNSCC patients. Top 100 differentially expressed lncRNAs shown, including ones that do not have FDR < .05. 2) Panel of Differentially Expressed lncRNAs with FDR between drinkers and nondrinkers. NETO1-1 and lnc-SLC39A11-2 are represented by different splice variants. 3) qRT-PCR analysis of ethanol-treated and acetaldehyde cell lines, OKF4 and OKF6, demonstrate that both PSD4-1 and NETO1- 1 are dysregulated by alcohol. Error bars represent standard deviation. 4) Survival information for PSD4-1:14 in both univariate and multivariate models demonstrates a strong correlation with low expression of PSD4-1:14 and better overall survival. 5) Kaplan-Meier survival graph depicting a correlation between low expression of lnc- PSD4-1:14 and better survival. Figure 1 Figure 2 Figure 3 Figure 4 Figure 5